Navigation Links
Actavis Confirms its Patent Challenge of King's Avinza(R)
Date:9/17/2007

MORRISTOWN, N.J., Sept. 17 /PRNewswire/ -- Actavis Group, the international generic pharmaceuticals company, today confirmed that Actavis Elizabeth L.L.C. has initiated a challenge of the patent listed in connection with King Pharmaceuticals' Avinza(R) (morphine sulfate extended-release capsules). Actavis believes that it is the first company to file an Abbreviated New Drug Application (ANDA) containing a paragraph IV certification for Avinza.

Actavis filed its ANDA for Avinza containing the paragraph IV certification with the U.S. Food and Drug Administration (FDA) in June 2007. Upon receiving filing acceptance from the FDA, Actavis Elizabeth LLC notified King Pharmaceuticals and the patent owner. On 10 September, 2007, King issued a press release that confirmed that it received Actavis Elizabeth's paragraph IV certification notice and that it intends to enforce its patent.

Avinza(R) capsules are a modified-release formulation of morphine sulfate intended for once daily administration indicated for the relief of moderate to severe pain requiring continuous, around-the-clock opioid therapy for an extended period of time. The product had annual sales of approximately US$169 million for a 12 month period, ending June 2007, according to IMS Health data.

About Actavis

Actavis is one of the world's leading generic pharmaceutical companies specializing in the development, manufacture and sale of generic pharmaceuticals. With headquarters in Iceland, Actavis has operations in 39 countries, with 11,000 employees. Actavis expects 2007 sales to total EUR1.6bn, with approximately one-third of these sales coming from the United States, the company's single largest market. In the U.S. alone, the company made 38 ANDA filings in 2006 and expects to file 40-45 in the year 2007 along with 18-20 new product launches. The company's U.S. operations are located in New Jersey, Maryland, North Carolina and Florida.

More information about Actavis in the
'/>"/>

SOURCE Actavis Group
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. SARS research confirms link to animals
2. Irritable bowel syndrome associated with food intake, confirms blood test
3. Skin tests confirms cancer
4. Roche confirms Tamiflu production talks in US
5. Local Test Confirms Bird Flu Related Death Of Indonesian Man
6. Surat in Gujarat,Confirms Bird flu Among Chickens
7. WHO Confirms Another Bird Flu Victim In Indonesia
8. Good news: there is no threat of bird flu confirms US
9. Orissa Confirms Bird’s Death In A Poultry Far
10. Interim WHO Chief Confirms No radical changes in WHO
11. China Confirms 19th Case Of Human Case Of Bird Flu

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)...ed for something leads to more self-defensive fing.... 29 (HealthDay News) -- The blame game is a conta...et is innocent. , Researchers found that when p..., even if it,s an unfair accusation, they,re much ..., "When we see others protecting their egos, we be...
(Date:11/28/2009)... 28 Welcome to syngo® ....inical routine from Siemens Healthcare. As the...em (PACS) from Siemens where 2D, 3D, and 4D read...is poised to change the way multimodality images a...n at the 95th Scientific Assembly and Annual Mee...
(Date:11/27/2009)..., Nov. 27 GSI Group Inc....f precision technology products and semiconductor ... the Company,s shareholders has been scheduled for... the meeting will be announced in due course. As ...sition notice from Stephen Bershad, a holder of gr...
(Date:11/27/2009)..., Nov. 27 Preventing di...d fortunately every year, new vaccines are being a...accines boost immunity for the same period of time... needed to keep immunity strong? ,, In this m...rican Academy of Pediatrics, Michael Pichichero MD...
(Date:11/27/2009)...ecedented medical, economic burdens, study predict...- The number of people with diabetes in the United...rs, a new study predicts. , That would bring th...the disease, up from 23.7 million today. , , At ...abetes will triple, the study also warns, rising f...
Breaking Medicine News(10 mins):Health News:When Accusations Start to Fly, They Multiply 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3Health News:GSI Group Calls Shareholders Meeting 2Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3
...I, China, June 10 /Xinhua-PRNewswire/ -- Fresenius...rthquake victims in the Chinese,province of Sichua...e,Company has donated a total of $1.1 million in b...t, services and,reconstruction assistance to hospi...
... down the interrelated effects of biomarkers most ...rous lives, PHOENIX, June 10 The Kronos Longevit...State of the Science, which,examines "the vicious ...ientists across the country are,studying how the i...
...INGTON, June 10 Today, Congresswoman,Stephanie Tu...s during a,Ways and Means Health Subcommittee Hear... "Mr. Chairman, I am appreciative of the opportuni...portance, not just to my district, but to,district...
...se,s Healthcare Company Captures ,Best of Healthca...d Straight Year, CHICAGO, June 10 Sonata(TM), fr...he Healthcare Furniture category in the,Best of Ne...www.newscom.com/cgi-bin/prnh/20080610/AQTU111 ), ...
...M, Pa., June 10 Law Offices of Howard G. Smith,an...a lead plaintiff in the,securities class action la... or otherwise acquired the common stock of Healthw...ed through,the Company,s Retirement Savings Plan. ...
...analysis of a drug approved for osteoporosis preve...ce that the medication is also effective as a brea... who took the drug raloxifene were less likely to ...ed trial will be published in the June 10 online i...
Other Medicine News:Health News:Fresenius Medical Care Supports Chinese Earthquake Victims 2Health News:New KLRI Reports Shows Longevity Science Moving Beyond Studying the Obvious to the 'Downward Spiral' Paradigm in the Aging Process 2Health News:New KLRI Reports Shows Longevity Science Moving Beyond Studying the Obvious to the 'Downward Spiral' Paradigm in the Aging Process 3Health News:Tubbs Jones Addresses Health Disparities Issue During Hearing 2Health News:Three-peat: Nurture(R) Strikes Gold Again at NeoCon 2Health News:Law Offices of Howard G. Smith Announces Update to the Shareholder Lawsuit Against Healthways, Inc. 2Health News:Anti-estrogen drug therapy reduces risk of invasive breast cancer in older women 2Health News:Anti-estrogen drug therapy reduces risk of invasive breast cancer in older women 3
(Date:11/29/2009)..., , CHICAGO, Nov. 29 At t...the Radiological Society of North America (RSNA), ...ens Healthcare booth (#825) from November 29 to De...ding/Lakeside Center, Hall D) in Chicago. This yea...e story of Siemens support for its customers to ge...
(Date:11/29/2009)..., , IOWA CITY, Iowa and ST. LOUIS, Nov. 2...loper of quantitative imaging software for the adv...dical Technologies, a leader in minimally invasive...nounced the companies have signed a definitive agr... of an endobronchial lung navigation and biopsy sy...
(Date:11/29/2009)..., , CHICAGO, Nov. 29 FUJI...n Full Field Digital Mammography (FFDM) with over ...e HD* FFDM system for the first time in the US. T...er amorphous selenium (a-Se) next generation detec...ver lower noise and higher spatial resolution at a...
Breaking Medicine Technology:Siemens Delivers Images per the Customer's Request - 'Images My Way' 2Siemens Delivers Images per the Customer's Request - 'Images My Way' 3Siemens Delivers Images per the Customer's Request - 'Images My Way' 4Siemens Delivers Images per the Customer's Request - 'Images My Way' 5Siemens Delivers Images per the Customer's Request - 'Images My Way' 6Siemens Delivers Images per the Customer's Request - 'Images My Way' 7Siemens Delivers Images per the Customer's Request - 'Images My Way' 8Siemens Delivers Images per the Customer's Request - 'Images My Way' 9VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 2VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 3VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 4FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 2FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 3FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 4Dr Siegals Cookie Diet Beats Balloon Boy Story on Googles Most Searched Topics List 59732 1Dr Siegals Cookie Diet Beats Balloon Boy Story on Googles Most Searched Topics List 59732 2Dr Siegals Cookie Diet Beats Balloon Boy Story on Googles Most Searched Topics List 59732 3PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum 59729 1PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum 59729 2PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum 59729 3PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum 59729 4Women and Men Face Off 3A Who Can Stand the Pain 3F 59726 1Women and Men Face Off 3A Who Can Stand the Pain 3F 59726 2Women and Men Face Off 3A Who Can Stand the Pain 3F 59726 3
...ovagali Pharma, a French,pharmaceutical ophthalmic... a,new Phase II clinical study with Cyclokat(R), i...trate statistically significant improvement,with s...ate-to-severe dry eye,syndrome. , For this dry...., a,leading global clinical research and developm...
...ollowing letter is being released by CEL-SCI Corpo... , Dear Fellow Shareholders: , , A very importan...reon Corporation has announced that its pivotal Ph...s primary endpoint of improving overall survival c...the 512 patient study will be presented on April 2...
Other Medicine Technology:Novagali Pharma Completed a New Phase II With Cyclokat(R) in Dry Eye 2CEL-SCI Corporation Releases Letter to Shareholders 2CEL-SCI Corporation Releases Letter to Shareholders 3
...emilene Mesh LP is a lightweight polypropylene mes...nsiderably reduced,foreign body reaction. The so...ation and pain. It perfectly conforms to,anatomi...remilene Mesh LP adapts to the movements of the pa...
Mega Power Electrosurgical Generator
...e advanced optical system of the Applied Fiberopti...field of illumination. There are six models to cho...s. Spot size ranges from 15 mm to 120 mm., ,Ea...ble with any of our quality fiberoptic cables and ...
...e patented Applied Fiberoptics Gemini surgical hea...rior optics. The headlight is durable and ultra-lo...ng surgeons to work closely without the annoying "...of white molded nylon, is designed to sit low on t...
Medicine Products: